Cedar Brook Financial Partners’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,200
| Closed | -$11K | – | 350 |
|
|
2022
Q2 | $11K | Hold |
2,200
| – | – | ﹤0.01% | 345 |
|
|
2022
Q1 | $17K | Hold |
2,200
| – | – | ﹤0.01% | 377 |
|
|
2021
Q4 | $19K | Hold |
2,200
| – | – | ﹤0.01% | 380 |
|
|
2021
Q3 | $62K | Hold |
2,200
| – | – | 0.02% | 344 |
|
|
2021
Q2 | $86K | Hold |
2,200
| – | – | 0.02% | 367 |
|
|
2021
Q1 | $103K | Hold |
2,200
| – | – | 0.04% | 315 |
|
|
2020
Q4 | $86K | Hold |
2,200
| – | – | 0.03% | 318 |
|
|
2020
Q3 | $56K | Hold |
2,200
| – | – | 0.02% | 289 |
|
|
2020
Q2 | $160K | Hold |
2,200
| – | – | 0.07% | 266 |
|
|
2020
Q1 | $116K | Hold |
2,200
| – | – | 0.06% | 238 |
|
|
2019
Q4 | $180K | Hold |
2,200
| – | – | 0.08% | 279 |
|
|
2019
Q3 | $124K | Hold |
2,200
| – | – | 0.05% | 293 |
|
|
2019
Q2 | $263K | Hold |
2,200
| – | – | 0.12% | 227 |
|
|
2019
Q1 | $405K | Hold |
2,200
| – | – | 0.2% | 160 |
|
|
2018
Q4 | $393K | Buy |
+2,200
| New | +$393K | 0.24% | 141 |
|